Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perrigo (NY: PRGO )

25.12 +0.23 (+0.92%)
Streaming Delayed Price Updated: 1:45 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,892
Open 24.91
Bid (Size) 25.11 (1)
Ask (Size) 25.13 (3)
Prev. Close 24.89
Today's Range 24.53 - 25.23
52wk Range 23.14 - 33.45
Shares Outstanding 136,500,000
Dividend Yield 4.39%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
JP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Nasdaq, S&P 500 Head for Worst Weekly Losses Since September
Stocks are higher midday, getting a much-needed lift from this morning's inflation data that came in line with estimates. 
Via Talk Markets
Topics Economy Stocks Stocks / Equities
Exposures Interest Rates US Equities

Performance

YTD
-3.38%
-3.38%
1 Month
-7.65%
-7.65%
3 Month
+1.49%
+1.49%
6 Month
+0.16%
+0.16%
1 Year
-19.56%
-19.56%

More News

Read More
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Earnings Scheduled For February 27, 2025
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
Via Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Via Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
Via InvestorPlace
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
Via Benzinga
$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
Via Benzinga
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
Via InvestorPlace
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Stocks Mixed As Consumer Confidence Falls
Via Talk Markets
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Insiders bet big on these turnaround stocks
Via MarketBeat
Topics Economy Initial Public Offering
Exposures Interest Rates Securities Market
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Via Benzinga
$1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.